Top Eminent Healthcare Group Limited (HKG:6877)
Hong Kong · Delayed Price · Currency is HKD 0.1000
0.00 (0.00%)
Sep 3, 2026, 3:26 PM HKT
HKG:6877 Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 26.83 | 22.21 | 9.35 | 33.77 | 13.23 | 195.49 |
Short-Term Investments | 1.15 | 1.15 | 1.17 | 1.19 | 4.23 | 39.23 |
Trading Asset Securities | - | - | - | - | - | 4.58 |
Accounts Receivable | 33.14 | 17.23 | 36.72 | 12.98 | 17.99 | - |
Other Receivables | 5.87 | 4.45 | 1.09 | 1.05 | 5.76 | 34.13 |
Property, Plant & Equipment | 0.02 | 0.02 | 0.08 | 0.39 | 0.85 | 11.15 |
Other Current Assets | 185.13 | 186.07 | 196.43 | 190.49 | 204.46 | 45.34 |
Other Long-Term Assets | - | - | - | - | - | 0.7 |
Total Assets | 275.21 | 246.44 | 279.38 | 251.78 | 284.31 | 330.62 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 30.65 | 1.51 | 29.73 | 7.7 | 43.4 | 42.27 |
Accrued Expenses | 1.76 | 4.25 | 2.2 | 2.01 | 4.39 | 9.15 |
Short-Term Debt | - | - | - | - | 0.01 | 0.46 |
Current Portion of Leases | - | - | - | - | - | 3.4 |
Other Current Liabilities | 0.01 | 0.01 | 0.06 | 0.15 | 3.2 | 0.35 |
Long-Term Leases | - | - | - | - | - | 6.24 |
Total Liabilities | 32.41 | 5.76 | 35.08 | 11.91 | 53.51 | 61.86 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 20.33 | 20.33 | 20.33 | 20.33 | 20.33 | 20.33 |
Additional Paid-In Capital | - | 180.49 | 180.49 | 180.49 | 180.49 | 180.49 |
Retained Earnings | - | -104.55 | -97.44 | -108.78 | -118.62 | -88.13 |
Comprehensive Income & Other | 222.47 | 144.41 | 140.92 | 147.82 | 148.59 | 156.06 |
Shareholders' Equity | 242.8 | 240.68 | 244.31 | 239.87 | 230.8 | 268.76 |
Total Liabilities & Equity | 275.21 | 246.44 | 279.38 | 251.78 | 284.31 | 330.62 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 0.01 | 10.1 |
Net Cash (Debt) | 27.98 | 23.36 | 10.52 | 34.95 | 17.45 | 229.19 |
Net Cash Growth | -12.69% | 122.12% | -69.91% | 100.31% | -92.39% | -33.88% |
Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.11 |
Filing Date Shares Outstanding | 2,033 | 2,033 | 2,033 | 2,033 | 2,033 | 2,033 |
Total Common Shares Outstanding | 2,033 | 2,033 | 2,033 | 2,033 | 2,033 | 2,033 |
Working Capital | 242.78 | 240.66 | 244.23 | 239.48 | 229.96 | 263.15 |
Book Value Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.13 |
Tangible Book Value | 242.8 | 240.68 | 244.31 | 239.87 | 230.8 | 268.76 |
Tangible Book Value Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.13 |